This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Wilhem Leconet, PhD
Senior Scientist, Antibody Research at Genmab


Wilhem Leconet, Ph.D., is a Senior Scientist at Genmab. He obtained his Ph.D. in 2014 in Immuno-oncology at the Pharmaceutical and Biological Sciences University of Montpellier (France), studying the signaling and antibody-based targeting of AXL tyrosine kinase receptor in cancer. He transitioned to industry as a post-doctoral fellow in a research collaboration project between MedinCell (France) and the Uro-Oncology research team of Dr. Neil H. Bander at Weill Cornell Medicine (New York, USA). He joined Genmab in 2020 where his focus is on the development of novel antibody formats in oncology.

Agenda Sessions

  • Antibodies Fc-engineered for Cell-surface Specific Assembly – Variations of IgG Hexamers and Agonistic Applications